Amgen (AMGN) Financials

$468.11

$2.88 (0.62%)

As on 11-Nov-2026 16:28EST

Market cap

$249,046 Mln

Revenue (TTM)

$38,933 Mln

P/E Ratio

26.7

P/B Ratio

17.3

Div. Yield

2.2 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	38,933.00	36,741.00	33,424.00	28,190.00	26,323.00	25,979.00
Cost of Revenue	10,133.00	10,729.00	12,858.00	8,451.00	6,406.00	6,454.00
Gross Profit	28,800.00	26,012.00	20,566.00	19,739.00	19,917.00	19,525.00
Operating Expenses	14,968.00	15,336.00	13,308.00	11,842.00	10,351.00	11,886.00
Operating Profit (EBIT)	13,832.00	10,676.00	7,258.00	7,897.00	9,566.00	7,639.00
Other Income	--	--	--	--	-814.00	259.00
Profit before Tax	11,052.00	8,976.00	4,609.00	7,855.00	7,346.00	6,701.00
Provision for Tax	1,661.00	1,265.00	519.00	1,138.00	794.00	808.00
Profit after Tax (Net Income)	9,391.00	7,711.00	4,090.00	6,717.00	6,552.00	5,893.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	6,552.00	5,893.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	14,352.00	8,658.00	5,877.00	6,232.00	3,661.00	6,700.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	58,465.00	56,439.00	62,863.00	72,530.00	45,773.00	42,281.00
Current Liabilities	23,231.00	25,489.00	23,099.00	18,392.00	15,687.00	12,184.00
Total Liabilities	119,279.00	90,586.00	91,839.00	97,154.00	65,121.00	61,165.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	61,685.00	61,529.00	62,809.00	66,822.00	42,935.00	41,780.00
Current Assets	34,363.00	29,057.00	29,030.00	30,332.00	22,186.00	19,385.00
Total Assets	119,279.00	90,586.00	91,839.00	97,154.00	65,121.00	61,165.00
Total Debt*	54,007.00	54,604.00	60,099.00	64,613.00	38,945.00	33,309.00
Net Current Assets	11,132.00	3,568.00	5,931.00	11,940.00	6,499.00	7,201.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	9,958.00	11,490.00	8,471.00	9,721.00	9,261.00
Cash Flow from Investing Activities	--	-1,943.00	-1,046.00	-26,204.00	-6,044.00	733.00
Cash from Financing Activities	--	-10,859.00	-9,415.00	21,048.00	-4,037.00	-8,271.00
Net Cash Inflow / Outflow	--	--	--	--	-360.00	1,723.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	17.24	14.20	7.55	12.44	12.16	10.43
Cash EPS ($)	--	23.72	17.86	19.11	18.50	16.44
Adjusted Book Value ($)	--	15.94	10.84	11.54	6.79	11.86
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	18.34	21.20	15.69	18.04	16.39
Free Cash Flow per Share ($)	--	14.92	19.18	13.63	16.30	14.83

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	11.93	5.98	11.84	15.86	14.30
ROE (%)	79.78	106.10	67.55	135.79	126.47	73.16
ROA (%)	8.12	8.45	4.33	8.28	10.38	9.50
EBIT Margin (%)	35.16	31.93	23.23	28.01	33.25	30.40
Net Margin (%)	24.12	20.99	12.24	23.83	25.69	22.46
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	8.27	0.10	0.19	0.07	0.01	0.02
EBIT Growth (%)	23.24	51.09	-1.68	-9.77	10.81	-15.93
Net Profit Growth (%)	34.06	88.53	-39.11	2.52	11.18	-18.87
EPS Growth (%)	33.29	0.88	-0.39	0.02	0.17	-0.16
Book Value Growth (%)	48.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	26.69	23.05	34.54	23.15	21.61	21.57
Price / Book Value	17.35	20.53	24.04	24.96	38.67	18.97
Dividend Yield (%)	2.16	--	--	--	--	--
EV/EBITDA	15.95	13.21	14.18	25.11	14.07	13.49
Close Price ($)	421.51	327.31	260.64	288.02	262.64	224.97
High Price ($)	447.01	346.38	346.85	289.04	296.67	276.69
Low Price ($)	283.00	257.05	253.30	211.71	214.39	198.64
Market Cap ($ Cr)	249,046.47	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	3.60	6.31	10.23	10.37	10.64	4.97
Short term debt to equity ratio	0.17	0.53	0.60	0.23	0.43	0.01
Current Ratio	1.48	1.14	1.26	1.65	1.41	1.59
Quick Ratio	1.20	0.90	0.95	1.13	1.10	1.26
Interest Coverage	5.19	4.26	2.46	2.75	6.22	6.60

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	26.59	26.05	22.44	28.17	24.28	22.48
Asset Turnover	0.34	0.40	0.35	0.35	0.42	0.42
Receivable days	--	84.85	84.38	92.86	84.86	72.86
Inventory Days	--	225.08	234.58	312.22	257.03	225.78
Payable days	--	72.77	49.68	68.33	83.76	78.86
Cash Conversion Cycle	--	237.16	269.28	336.75	258.13	219.77

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)